Immunotherapy highlights in multiple myeloma at ASH 2016
Niels van de Donk
Assessment of response in multiple myeloma: next steps
Utilizing new understanding in multiple myeloma biology to guide treatment
How can standard risk multiple myeloma (MM) patients be cured?
Which is the best combination therapy in relapsed and refractory multiple myeloma?